SCHEMBL6940554

SCHEMBL6940554

CC(C)N1CC(C)N(C(C)C)C1=O

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12594213 1.00 MAPT (0.37) MAPTSMN1; SMN2POLB
SCHEMBL12594212 1.00 MAPT (0.37) MAPTSMN1; SMN2POLB
SCHEMBL14554141 0.78 MAPT (0.37) MAPT
SCHEMBL12648596 0.78 ACE (0.35)
SCHEMBL14554150 0.78 ACE (0.35)
SCHEMBL8633574 0.78 ACE (0.35)
SCHEMBL25668851 0.75 L3MBTL1 (0.36)
SCHEMBL25995915 0.75 KMT2A (0.33)
SCHEMBL13574982 0.74 PIK3CD (0.31)
SCHEMBL8629144 0.74 PIK3CD (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2703379-B1 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME NIPPON CARBIDE KOGYO KK (JP) 2016-11-30 EP claimed
US-9156762-B2 4,4-bis[(ethenyloxy)methyl]cyclohexene and method for producing same NIPPON CARBIDE INDUSTRIES CO., INC. (JP) 2015-10-13 US claimed
EP-2703379-A1 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME Nippon Carbide Industries Co., Inc. (JP) 2014-03-05 EP claimed
US-20140058136-A1 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME NIPPON CARBIDE INDUSTRIES CO., INC. (JP) 2014-02-27 US claimed
EP-2703379-B1 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME NIPPON CARBIDE KOGYO KK (JP) 2016-11-30 EP disclosed
US-9156762-B2 4,4-bis[(ethenyloxy)methyl]cyclohexene and method for producing same NIPPON CARBIDE INDUSTRIES CO., INC. (JP) 2015-10-13 US disclosed
EP-2703379-A1 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME Nippon Carbide Industries Co., Inc. (JP) 2014-03-05 EP disclosed
US-20140058136-A1 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME NIPPON CARBIDE INDUSTRIES CO., INC. (JP) 2014-02-27 US disclosed
CN-1210264-C 1,3-dialkyl-2-imidazolinones and its prepn. MITSUI CHEMICALS INC (JP) 2005-07-13 CN disclosed
EP-0992497-B1 Manufactoring process for 1,3-Dialkyl-2-imidazolinones MITSUI CHEMICALS INC (JP) 2003-12-17 EP disclosed
US-6492528-B1 1,3-DIALKYL-2-IMIDAZOLIDINONES IN A DIRECT ONE-STEP REACTION FROM INDUSTRIALLY AVAILABLE ALKYLENE CARBONATE, N-ALKYLETHANOLAMINE OR 1,2-DIOL, WHICH CAN MINIMIZE FORMING SOLID MATERIALS AND BE READILY CONDUCTED IN AN INDUSTRIAL MITSUI CHEMICALS, INC. (JP) 2002-12-10 US disclosed
EP-1148051-A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2001-10-24 EP disclosed
EP-1148052-A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2001-10-24 EP disclosed
EP-0992497-A1 1,3-Dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2000-04-12 EP disclosed
EP-0718291-B1 Method for the preparation of triazole compounds CHUGAI PHARMACEUTICAL CO LTD (JP) 1998-07-08 EP disclosed
US-5567825-A Method for the preparation of a triazole compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1996-10-22 US disclosed
EP-0718291-A1 Method for the preparation of triazole compounds CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1996-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140058136-A1 4,4-BIS[(ETHENYLOXY)METHYL]CYCLOHEXENE AND METHOD FOR PRODUCING SAME OR10J3, CUTA, OR51E2 MAPT 1836/4885SMN1; SMN2 3887/4885POLB 2259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.